Eesti - eesti - Ravimiamet

bimeda animal health limited - oksütetratsükliin - süstelahus - 200mg 1ml 100ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil vesinikkloriid - kolorektaalne kasvaja - antineoplastilised ained - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Euroopa Liit - eesti - EMA (European Medicines Agency)

les laboratoires servier - irinotecan anhydrous free-base - pankrease neoplasmid - antineoplastilised ained - metastaatilise ravi, koos 5-fluorouratsiili (5-fu) ja leukovoriiniga (lv), täiskasvanud patsientidel, kelle haigus pärast gemtsitabiini ravi põhineb ravi.

Euroopa Liit - eesti - EMA (European Medicines Agency)

actavis group ptc ehf - reteplaas - müokardi infarkt - antitrombootilised ained - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

Euroopa Liit - eesti - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - treosulfan - hematopoeetiline tüvirakkude siirdamine - antineoplastilised ained - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.

Eesti - eesti - Ravimiamet

fresenius kabi oncology plc - epirubitsiin - süste-/infusioonilahus - 2mg 1ml 5ml 1tk; 2mg 1ml 50ml 1tk

Eesti - eesti - Ravimiamet

ferring gmbh - terlipressiin - süstelahus - 0,1mg 1ml 8.5ml 5tk

Eesti - eesti - Ravimiamet

b. braun melsungen ag - joodpovidoon - nahalahus - 75mg 1g 100ml 1tk; 75mg 1g 1000ml 1tk

Eesti - eesti - Ravimiamet

teva b.v. - epirubitsiin - süstelahus - 2mg 1ml 100ml 1tk; 2mg 1ml 5ml 1tk; 2mg 1ml 25ml 1tk; 2mg 1ml 10ml 1tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - epirubitsiin - süste-/infusioonilahuse kontsentraat - 2mg 1ml 50ml 1tk; 2mg 1ml 100ml 1tk; 2mg 1ml 5ml 1tk